Detalhe da pesquisa
1.
Associations of TACSTD2/TROP2 and NECTIN-4/NECTIN-4 with molecular subtypes, PD-L1 expression, and FGFR3 mutational status in two advanced urothelial bladder cancer cohorts.
Histopathology
; 84(5): 863-876, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38196202
2.
Prognostic impact of molecular muscle-invasive bladder cancer subtyping approaches and correlations with variant histology in a population-based mono-institutional cystectomy cohort.
World J Urol
; 39(11): 4011-4019, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34259899
3.
Utility of stromal tumor infiltrating lymphocyte scoring (sTILs) for risk stratification of patients with muscle-invasive urothelial bladder cancer after radical cystectomy.
Urol Oncol
; 40(2): 63.e19-63.e26, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34420870
4.
Bladder Tumor Subtype Commitment Occurs in Carcinoma In Situ Driven by Key Signaling Pathways Including ECM Remodeling.
Cancer Res
; 81(6): 1552-1566, 2021 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33472889
5.
TERT Promoter Mutation Analysis of Whole-Organ Mapping Bladder Cancers.
Genes (Basel)
; 12(2)2021 02 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33562516
6.
Integration of Spatial PD-L1 Expression with the Tumor Immune Microenvironment Outperforms Standard PD-L1 Scoring in Outcome Prediction of Urothelial Cancer Patients.
Cancers (Basel)
; 13(10)2021 May 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34066058
7.
Cytotoxic T-cell-related gene expression signature predicts improved survival in muscle-invasive urothelial bladder cancer patients after radical cystectomy and adjuvant chemotherapy.
J Immunother Cancer
; 8(1)2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32448798